Jerel Davis - 03 Jan 2022 Form 4/A - Amendment Insider Report for CHINOOK THERAPEUTICS, INC.

Role: Director, 10%+ Owner
Signature: /s/ Robin L. Praeger, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 03 Mar 2022, 15:28:10 UTC
Date Of Original Report: 05 Jan 2022
Previous filing: 31 Aug 2021
Next filing: 06 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KDNY	Common Stock						730,470	03 Jan 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This amended Form 4 is being filed to correct an inadvertent omission from the Reporting Person's Form 4s filed on August 27, 2021 and January 5, 2022 (the "Prior Form 4s"), which omitted the securities held directly by the Reporting Person. This Form 4 amendment amends the Prior Form 4s by including the Reporting Person's direct holdings.